Complementary Health Practice Review

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

The Diabetes Educator

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Google Scholar
Right arrow Articles by Bristol, M. N.
Right arrow Articles by Guerra, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Complementary Health Practice Review, Vol. 13, No. 2, 100-109 (2008)
DOI: 10.1177/1533210108317281
© 2008 SAGE Publications

Uninformed Complementary and Alternative Supplement Use: A Risky Behavior for Cardiovascular Patients

Mirar N. Bristol, BA

School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, mirar.bristol{at}uphs.upenn.edu

Seema S. Sonnad, PhD

School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Carmen Guerra, MD

School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Growing use of complementary and alternative supplements (CAS) is of concern because of the potential for herb—drug interaction among cardiovascular patients. Literary searches were conducted on PubMed to identify reports of extent and purpose of CAS use, disclosure of use by patients, physician knowledge, and possible drug—CAS interactions for cardiovascular patients. Additional published studies were located through the Web sites of various organizations. Further searches of case reports, case series, controlled trials, and laboratory evidence were performed for each of the top 10 CAS and their possible cardiovascular drug interactions. More research is needed to understand supplement—drug interactions, particularly in terms of how this potentially affects patients taking cardiovascular drugs. With this lack of research and clarity on supplement—dug interactions and the underreporting of CAS use by many patients, physician education is also in need of improvement.

Key Words: complementary therapies • dietary supplements • cardiovascular disease • herb—drug interactions


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?